Insight by Abdul Wasay, Chief Operating Officer at The Business Research Company In response to fluctuating tariffs and geopolitical trade developments, the Medical Isotopes Market Outlook 2025 analyses how businesses are adapting through supply chain diversification and strategic sourcing.
The Medical Isotopes market has exhibited significant growth recently. It was valued at $6.8 billion in 2024 and is projected to rise to $7.26 billion in 2025. This represents a compound annual growth rate (CAGR) of 6.7%.
By 2029, the market size of Medical Isotopes is projected to reach $9.5 billion with a compound annual growth rate (CAGR) of 7.0%.
Download the Free Sample Now:The key Drivers in the medical isotopes market are:
• Surge in cancer and heart disease rates
• Widespread sedentary lifestyle associated with increased disease prevalence
• Use of medical isotopes in diagnosis and treatment of diseases through imaging techniques
• Growth in radioactive therapies and stents used in treatment of cancer and heart disease
The medical isotopesmarket covered in this report is segmented –
1) By Product Type: Stable Isotopes, Radio Isotopes
2) By Production Method: Neutron Activation, Cyclotron, Nuclear Reactor, Other Production Method
3) By Application: Nuclear Therapy, Equipment Radioactive Source, Diagnosis
4) By End Use: Hospitals, Diagnostic Centers, Research Institutes
The key trends in the medical isotopes market are:
• Strategic collaborations and partnerships are becoming prevalent in the medical isotope market.
• Companies are increasingly integrating solutions to enhance customer experience.
• The focus on innovating calibration and reference sources is a rising trend.
• There is also a growing interest in catering to the medical imaging and theranostic communities.
The key players in the medical isotopes market are:
• Rosatom State Atomic Energy Corporation
• Bayer AG
• Siemens Healthineers AG
• GE HealthCare
• Urenco Ltd.
• Lantheus Holdings Inc.
• Curium Pharma
• Canadian Nuclear Laboratories
• Eckert & Ziegler Strahlen- und Medizintechnik AG.
• Advanced Accelerator Applications, a Novartis company
• Nordion Inc.
• NTP Radioisotopes SOC Ltd.
• The Institute for Radioelements (IRE)
• NorthStar Medical Radioisotopes LLC
• Isotopen Technologien München AG (ITM)
• Eczacibasi-Monrol Nuclear Products Co.
• SHINE Medical Technologies LLC
• Blue Earth Diagnostics Limited
• Isologic Innovative Radiopharmaceuticals
• IBA Radiopharma Solutions
• Izotóp
• Coquí RadioPharmaceuticals Corp.
• Jubilant DraxImage Inc.
• Positron Corporation
North America was the largest region in the medical isotopes market in 2024